Anti IgE Treatment May Help Allergic Asthma in Children

At a recent conference in the US results were published that the anti-IgE monoclonal antibody Omalizumab (Xolair) reduced allergic asthma exacerbations in children as young as six.

This is a new treatment not yet licenced in children, but has the potential to be extremely helpful in helping those with severe allergic asthma. There are also hopes that Omalizumab may have a role in controlling severe food allergy - particularly nut an dpeanut allergy,